Business Context and Reporting Period
Company: Charles River Laboratories International, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2026
Reporting Period: First quarter ended March 28, 2026
This filing serves to announce the issuance of a press release containing financial results for the first quarter of 2026. The document itself does not contain the detailed financial data but references the attached press release (Exhibit 99.1) as the source of the results.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The referenced press release includes "safe harbor" language under the Private Securities Litigation Reform Act of 1995, indicating the presence of forward-looking statements rather than historic facts.
- Risks: The filing states that risks relating to Charles River are set forth in documents previously filed with the Securities and Exchange Commission.
- Unusual Items: No unusual items are described in the text of this 8-K filing.
Important Facts for Investor Verification
- Verify the specific Q1 2026 financial results (revenue, earnings, cash flow) in the attached press release (Exhibit 99.1), as they are not listed in this summary text.
- Review the "safe harbor" language in the press release to understand the assumptions and risks associated with any forward-looking guidance.
- Consult prior SEC filings for a comprehensive list of risk factors referenced in this report.
- Confirm the exact quarter end date of March 28, 2026, for accurate period-over-period comparisons.